Orphan designation: 2-(3-Chlorophenyl)-N-[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]acetamide Treatment of amyotrophic lateral sclerosis, 21/11/2025 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 10 April 2026 - 10:26

Orphan designation: 2-(3-Chlorophenyl)-N-[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]acetamide Treatment of amyotrophic lateral sclerosis, 21/11/2025 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3148

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters